United Kingdom Archives

News and Trends 17 Dec 2021

UK Startup Lands €5M Seed Round to Produce Gene-Edited Crops with AI

Phytoform, a London- and Boston-based startup, has received a €5M ($5.7M) investment to develop gene-edited crops with the help of artificial intelligence tools. The firm expects to bring its first product, a weather-resistant tomato, to market in early 2022. The seed financing will fuel the development of Phytoform’s precision crop breeding platform, which specializes in […]

December 17, 2021 - 4 minutesmins - By Dan Samorodnitsky

London UK venture capital adendra therapeutics apple tree partners

News and Trends 14 Dec 2021

ATP Blazes US Venture Capital Trail into European Biotech Startups

The US venture capital firm Apple Tree Partners (ATP) is making its first transatlantic foray by launching the UK immuno-oncology company Adrendra Therapeutics. This happens as US investors increasingly search for value-for-money opportunities in early-stage European biotech startups. Last week, the life science-focused investor ATP contributed €47M (£40M) to the Series A launch of immunotherapy […]

December 14, 2021 - 4 minutesmins - By Anita Chakraverty

cell therapy manufacturing reprogramming synbio

News and Trends 22 Nov 2021

Investors Flock to Startups Reprogramming Cell Therapies

Painstaking and expensive procedures are required to produce human cells for use in research and cell therapies. Investors are seeking stakes in cell reprogramming startups that can free up the bottleneck, such as Mogrify, bit.bio, and Asgard Therapeutics. The concept of cell reprogramming — converting one type of cell into another — has been hot […]

November 22, 2021 - 7 minutesmins - By Jonathan Smith

News and Trends 12 Nov 2021

Big Pharma Strikes Megadeals In Targeted Protein Degradation

With many targeted protein degraders hitting the clinic, lucrative collaborations and acquisitions are being signed between biotech startups and big pharma in this upcoming area. Novartis, Pfizer, and Bayer have all negotiated billion Euro deals this year with smaller biotechs including Dunad Therapeutics, Arvinas, and Vividion Therapeutics. The big pharma companies aim to gain a […]

November 12, 2021 - 5 minutesmins - By Anita Chakraverty

News and Trends 28 Oct 2021

DNA Manufacturing Startups Net Venture Capital Windfalls

Touchlight Genetics and DNA Script have closed major venture financing rounds in the last month as investor excitement mounts over the next generations of DNA manufacturing. DNA Script made a big splash in Paris this week as it raked in €142M in Series C funding. The company will ramp up the commercialization of its benchtop […]

October 28, 2021 - 6 minutesmins - By Jonathan Smith

oxford nanopore technologies genomics sequencing

News and Trends 15 Oct 2021

Third-Generation DNA Sequencing Shines with Oxford Nanopore’s IPO

Oxford Nanopore Technologies, until recently one of very few unicorns in the European biotech industry, had a stellar IPO on the London Stock Exchange late last month. This is ushering in a whole new generation of DNA sequencing, genetics research, and diagnostics. During the first day of the IPO, which bagged the firm over €400M […]

October 15, 2021 - 5 minutesmins - By Victor Kotsev

News and Trends 7 Oct 2021

Exscientia IPO Attracts Tech Investor Bets to AI Drug Discovery

Exscientia’s lucrative entry onto the Nasdaq last week demonstrated investors are still excited by efforts to use artificial intelligence to fuel drug discovery, with global tech investors often taking the lead. The Oxford, UK-based company Exscientia has one of the most mature artificial intelligence (AI)-focused drug discovery pipelines, alongside companies like BenevolentAI in the UK, […]

October 7, 2021 - 5 minutesmins - By Mark Zipkin

News and Trends 24 Sep 2021

Breath Testing To Be Tapped by UK Pioneer with €50M Fundraising

After years of under-fulfilled promise, breath tests for cancer, liver disease, and respiratory conditions appear to be taking off with UK biotech Owlstone Medical raking in almost €50M (£42M) in an oversubscribed Series D funding round. The round, whose original target was about €43M, was led by the Hong Kong-based Horizons Ventures and was joined […]

September 24, 2021 - 3 minutesmins - By Victor Kotsev

News and Trends 15 Sep 2021

UK Startup Surfs Investment Wave in Microbiome with €18M Series A

As increasing attention turns to microbiome-based therapeutics, the Scottish biotech Enterobiotix has closed a Series A fundraising to potentially treat a myriad of medical conditions by improving gut health. Last week, EnteroBiotix raised €18M (£15.5M) in Series A funding to further develop a pill to restore the patient’s gut microbiome to a healthy state using […]

September 15, 2021 - 4 minutesmins - By Anita Chakraverty

psychedelics psychiatric atai gh compass

News and Trends 24 Aug 2021

UK Venture Round Shines Spotlight on Europe’s Psychedelics Scene

The UK has cemented its position as a European hub for psychedelics research following a €68.5M ($80M) Series B round from the startup Beckley Psytech. The Oxford-based Beckley Psytech — founded in 2019 to develop psychedelic treatments for neurological conditions — had originally set the target of its venture capital financing at €43M ($50M). Earlier […]

August 24, 2021 - 4 minutesmins - By Jonathan Smith

News and Trends 30 Jul 2021

British Diagnostics Biotech Becomes Social Enterprise After Acquisition

UK rapid diagnostics company Mologic will convert into a social enterprise after being acquired by a group of philanthropic funds and investors, in what experts predict may become an increasingly popular trend. The British biotech Mologic will entirely reinvest any profits into widening global access to affordable medical technology after being acquired in a deal […]

July 30, 2021 - 4 minutesmins - By Anita Chakraverty

News and Trends 28 Jul 2021

Microbiome Medicines Could Power Up CAR-T Cell Therapies

The microbiome could pave new cancer immunotherapy inroads for European biotechs, bolstered by preclinical findings that gut bacteria metabolites may help CAR-T cell therapies penetrate and kill solid tumors. A recent study conducted by researchers at Philipps-University Marburg, University Hospital Würzburg, and the Leeds-based company 4D Pharma showed that metabolites produced by the gut bacteria […]

July 28, 2021 - 5 minutesmins - By Mark Zipkin

Knowledge hub

Categories

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Approaches

Therapeutic areas

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

United Kingdom

UK Startup Lands €5M Seed Round to Produce Gene-Edited Crops with AI

ATP Blazes US Venture Capital Trail into European Biotech Startups

Investors Flock to Startups Reprogramming Cell Therapies

Big Pharma Strikes Megadeals In Targeted Protein Degradation

DNA Manufacturing Startups Net Venture Capital Windfalls

Third-Generation DNA Sequencing Shines with Oxford Nanopore’s IPO

Exscientia IPO Attracts Tech Investor Bets to AI Drug Discovery

Breath Testing To Be Tapped by UK Pioneer with €50M Fundraising

UK Startup Surfs Investment Wave in Microbiome with €18M Series A

UK Venture Round Shines Spotlight on Europe’s Psychedelics Scene

British Diagnostics Biotech Becomes Social Enterprise After Acquisition

Microbiome Medicines Could Power Up CAR-T Cell Therapies

Subscribe to our newsletter to get the latest biotech news!

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!